#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Mitophagy links oxidative stress conditions and neurodegenerative diseases"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Esther Wollert"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns"
# DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns"
# DEFINE NAMESPACE DOID           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns"
# DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/ec-code.belns"
# DEFINE NAMESPACE FB             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns"
DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE HP             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hp-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns"
# DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
# DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mirbase-names.belns"
# DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/ncbigene.belns"
# DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/pfam-names.belns"
# DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
# DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
# DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
# DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
# DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
# DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
# DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
# DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
# DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
# DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
# DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
# DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
# DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############

SET Citation = {"PubMed", "30688256"}

SET Evidence = "Mitophagy is induced by oxidative stress."
path(MESH:"Oxidative Stress") -> bp(GO:mitophagy)

SET Evidence = "Direct production
of mitochondrial ROS by using a mitochondrial-targeted
photosensitizer can also induce mitophagy (Wang et al.,
2012). "
SET MeSHAnatomy = "Mitochondria"
a(CHEBI:"reactive oxygen species") -> bp(GO:mitophagy)
UNSET MeSHAnatomy

SET Evidence = " The induction of autophagy results in the recruitment
of autophagy-related genes (Atgs) to a particular subcellular
location, termed the phagophore assembly site, and nucle-
ation of an isolation membrane that forms a cup-shaped
structure, termed a phagophore (Figure 1). "
bp(GO:autophagy) -> a(MESH:"Autophagy-Related Proteins", loc(GO:"phagophore assembly site"))
a(MESH:"Autophagy-Related Proteins", loc(GO:"phagophore assembly site")) -> a(GO:phagophore)

SET Evidence = "In the mutant mice,
neurons lacked Atg5 or Atg7, and animals experienced con-
tinuous neurodegeneration (Koike et al., 2008)."
SET Species = "10090"
p(MGI:Atg5) -| path(HP:Neurodegeneration)
p(MGI:Atg7) -| path(HP:Neurodegeneration)
UNSET Species

SET Evidence = " According
to another experiment, rapamycin, which is involved in au-
tophagy induction, conferred protection in animal models
of neurodegenerative diseases (Sarkar et al., 2008)."
a(CHEBI:sirolimus) -> bp(GO:autophagy)
a(CHEBI:sirolimus) -| path(MESH:"Neurodegenerative Diseases")

SET Evidence = "Additionally, NIX, which is also known as beclin-2 (BCL2)/
adenovirus E1B 19 kDa protein-interacting protein 3-like
(BNIP3L), is transcriptionally upregulated in the period of
reticulocyte maturation to erythrocytes."
p(HGNC:BNIP3L) pos bp(GO:"erythrocyte maturation")

SET Evidence = " NIX/BNIP3L inter-
acts directly with LC3B or Golgi-associated ATPase Enhancer
of 16 kDa (GATE-16) via an LC3-interacting region (LIR),
hence mediating the sequestration of NIX-expressing mito-
chondria via the growing phagophore (Novak et al., 2010). "
complex(p(HGNC:GABARAPL2),p(HGNC:BNIP3L)) -> a(GO:phagophore)
complex(p(HGNC:MAP1LC3B),p(HGNC:BNIP3L)) -> a(GO:phagophore)

SET Evidence = "Mitophagy is a selective form of autophagy that removes
dysfunctional mitochondria and their harmful byproducts
and oxidative species to help maintain homeostasis."
bp(GO:mitophagy) isA bp(GO:autophagy)
bp(GO:mitophagy) -> deg(a(MESH:Mitochondria))
bp(GO:mitophagy) -| path(HBP:"mitochondrial dysfunction")

SET Evidence = "PINK1 is a mitochondri-
al-targeted serine/threonine kinase that plays a protective
role against mitochondrial dysfunction and apoptosis with
mitochondrial quality control by activating PINK1/PAR-
KIN-induced mitophagy (Figure 2) (Fivenson et al., 2017). "
p(HGNC:PINK1) -| path(HBP:"mitochondrial dysfunction")
p(HGNC:PINK1) -| bp(GO:"apoptotic process")
p(HGNC:PINK1) -> bp(GO:mitophagy)

SET Evidence = "The role of PINK1 has been
well-documented in neurodegenerative and aging-related
diseases (Li and Hu, 2015). "
p(HGNC:PINK1) -- path(MESH:"Neurodegenerative Diseases")

SET Evidence = "The cytosolic E3 ubiquitin ligase PARKIN and mitochon -
drial PINK1 have been implicated in the abnormal expres-
sion of genes associated with a recessive form of Parkinson-
ism (Schiavi and Ventura, 2014). "
p(HGNC:PRKN) -- path(MESH:"Parkinson Disease")
SET MeSHAnatomy = "Mitochondria"
p(HGNC:PINK1) -- path(MESH:"Parkinson Disease")
UNSET MeSHAnatomy

SET Evidence = "PINK1 is then degrad-
ed by various proteases, such as mitochondria-processing
protease (MPP + ), the inner membrane presenilin-related
rhomboid-like protease (Meissner et al., 2011)."
#MPP+ is complex(p(HGNC:PMPCA),p(HGNC:PMPCB))
complex(p(HGNC:PMPCA),p(HGNC:PMPCB)) => deg(p(HGNC:PINK1))

SET Evidence = " Following
mitochondrial depolarization, PINK1 is translocated to the
inner mitochondrial membrane, degraded, and sustained on
the mitochondrial membrane (Lazarou et al., 2012)."
bp(GO:"mitochondrial depolarization") -> p(HGNC:PINK1, loc(GO:"mitochondrial inner membrane"))
p(HGNC:PINK1, loc(GO:"mitochondrial inner membrane")) -> deg(p(HGNC:PINK1))

SET Evidence = "The ag -
gregation of PINK on the mitochondrial surface induces mi-
tophagy by volunteering PARKIN to degrade mitochondria
via a mechanism that is not completely understood. "
p(HGNC:PINK1, loc(GO:"mitochondrial outer membrane")) -> act(p(HGNC:PRKN))
act(p(HGNC:PRKN)) -> deg(a(MESH:Mitochondria))

SET Evidence = "Translocation of PARKIN to damaged mitochondria has
been shown to weaken PINK1 function (Geisler et al., 2010)."
p(HGNC:PRKN, loc(MESH:Mitochondria)) -| act(p(HGNC:PINK1))

SET Evidence = "The mitochondrial fusion proteins
mitofusion 1 (Mfn1) and mitofusion 2 (Mfn2) have been
recognized as substrates of PARKIN (Rakovic et al., 2011),
as illustrated in Figure 2. "
p(HGNC:PRKN) -> p(HGNC:MFN1, pmod(Ub))
p(HGNC:PRKN) -> p(HGNC:MFN2, pmod(Ub))

SET Evidence = "PARKIN hinders mitochondrial
fusion via the degeneration of mitofusions, thus isolating
damaged mitochondria from the healthy mitochondrial
membrane proteins, such as the voltage-dependent anion
channel (VADC), the mitochondrial RhoGTase (MIRO) 1
(Figure 2) and constituents of the mitochondrial translo-
case complex (TOM70, TOM40 and TOM20) (Yoshii et al.,2011)."
p(HGNC:PRKN) -| bp(GO:"mitochondrial fusion")
p(HGNC:PRKN) -> deg(p(HGNC:MFN1))
p(HGNC:PRKN) -> deg(p(HGNC:MFN2))
p(HGNC:MFN1) -> bp(GO:"mitochondrial fusion")
p(HGNC:MFN2) -> bp(GO:"mitochondrial fusion")

SET Evidence = "It is important to note that mitochondrial mobility is
strongly maintained by the mitochondrial MIROs."
p(HGNCGENEFAMILY:"Miro like atypical Rho GTPases") -> bp(GO:"axonal transport of mitochondrion")

SET Evidence = "Recessive mutations in PINK1 and PARKIN can cause
PD and lead to a failure of mitophagy, causing mitochon-
drial damage (Kahle et al., 2009) and contributing to disease
pathogenesis."
p(HGNC:PRKN, var("?")) -> path(MESH:"Parkinson Disease")
p(HGNC:PINK1, var("?")) -> path(MESH:"Parkinson Disease")
p(HGNC:PRKN, var("?")) -| bp(GO:mitophagy)
p(HGNC:PINK1, var("?")) -| bp(GO:mitophagy)
p(HGNC:PRKN, var("?")) -> path(HBP:"mitochondrial dysfunction")
p(HGNC:PINK1, var("?")) -> path(HBP:"mitochondrial dysfunction")

SET Evidence = "Mitochondrial fission is also important for the
function of neurons: dominant-negative dynamin-associated
protein 1 (Drp1) mutation can cause a lethal infantile neuro-
degenerative phenotype."
bp(GO:"mitochondrial fission") -> act(a(MESH:Neurons))
p(HGNC:DNM1L, var("?")) -> path(HP:Neurodegeneration)

SET Evidence = " Drp1 knockout mice revealed em-
bryonic lethality characterized by aberrant development of the
brain and failure of synapse formation (Dagda et al., 2009)."
SET Species = "10090"
p(HGNC:DNM1L) -> bp(GO:"brain development")
p(HGNC:DNM1L) -> bp(GO:"synapse assembly")

SET Evidence = " A recent study showed that resveratrol
weakened AÎ² 1â42 -induced cell death and significantly in-
creased mitophagy "
SET MeSHDisease = "Alzheimer Disease"
a(CHEBI:resveratrol) -| act(a(CHEBI:"amyloid-beta polypeptide 42"))
a(CHEBI:resveratrol) -| bp(GO:"apoptotic process")
a(CHEBI:resveratrol) -> bp(GO:mitophagy)
UNSET MeSHDisease

SET Evidence = "AÎ² is transported to mito-
chondria where it interacts with mitochondrial proteins,
causing an increase in ROS production, excess accumulation
of mitochondrial Ca 2+  and mitochondrial fragmentation, a
decrease in the number of functionally active mitochondria
and, ultimately, neuronal damage (Duchen, 2012)."
SET MeSHAnatomy = "Mitochondria"
a(CHEBI:"amyloid-beta", loc(MESH:Mitochondria)) -> a(CHEBI:"reactive oxygen species")
a(CHEBI:"amyloid-beta", loc(MESH:Mitochondria)) -> a(CHEBI:"calcium(2+)")
a(CHEBI:"amyloid-beta", loc(MESH:Mitochondria)) -| act(a(MESH:Mitochondria))
UNSET MeSHAnatomy
a(CHEBI:"amyloid-beta", loc(MESH:Mitochondria)) -| a(MESH:Neurons)

SET Evidence = "In an
APP transgenic mouse model, the down- or up-regulation
of Bcl-1 enhanced or decreased, respectively, extracellular
AÎ² aggregation and neurodegeneration, highlighting the
importance of mitophagy in AD-associated pathology."
#Bcl1 is CCND1
p(HGNC:CCND1) -| a(HBP:"amyloid-beta aggregates", loc(MESH:"Extracellular Space"))
p(HGNC:CCND1) -| path(HP:Neurodegeneration)

SET Evidence = " Fur-
thermore, a correlation between flavin adenine dinucleotide
(FAD) and autophagy was currently noted, reporting that
autophagy needs functional presenilin (PS-1) for lysosomal
maturation, which is altered by Alzheimer-related presenilin
1 (PS-1) mutations (Lee et al., 2010)."
a(CHEBI:FAD) -- bp(GO:autophagy)
p(HGNC:PSEN1) -> bp(GO:autophagy)
p(HGNC:PSEN1, var("?")) pos path(MESH:"Alzheimer Disease")
p(HGNC:PSEN1, var("?")) -| bp(GO:autophagy)

SET Evidence = "Hence, PS-1 alterations
may indirectly affect mitochondrial function by impairing
its recycling by mitophagy (GarcÃ­a-Escudero et al., 2013). "
p(HGNC:PSEN1, var("?")) -| act(a(MESH:Mitochondria))
p(HGNC:PSEN1, var("?")) -| path(GO:mitophagy)

SET Evidence = "Using transgenic Drosophila expressing human tau, Iiji-
ma-Ando et al. (2012) demonstrated that RNAi-mediated
Drosophila Miro (dMiro) knockdown enhanced human tau
phosphorylation at the AD-related site Ser262 (phopgo-tau),
resulting in enhanced levels of active PAR-1 and increased
tau-mediated neurodegeneration."
SET Species = "7227"
#PAR-1 is homolog of human MARK
p(HGNCGENEFAMILY:"Miro like atypical Rho GTPases") -| p(HGNC:MAPT,pmod(Ph,Ser,262))
p(HGNCGENEFAMILY:"Miro like atypical Rho GTPases") -| act(p(HGNC:MARK1))
p(HGNCGENEFAMILY:"Miro like atypical Rho GTPases") -| path(HP:Neurodegeneration)

SET Evidence = "In dopaminergic neurons of the
substantia nigra (SN), PD proteins such as Parkin, PINK1,
DJ-1, and leucine-rich repeat serine/threonine-protein
kinase 2 (LARRK2) as well as Î±-synucelin, play important
roles in preventing cell death by maintaining normal mito-
chondrial function, protecting against oxidative stress, me-
diating mitophagy, and preventing apoptosis (Mukherjee et
al., 2015). "
SET MeSHAnatomy = "Substantia Nigra"
SET Cell = "dopaminergic neuron"
p(HGNC:PRKN) -| bp(GO:"apoptotic process")
p(HGNC:PINK1) -| bp(GO:"apoptotic process")
p(HGNC:PARK7) -| bp(GO:"apoptotic process")
p(HGNC:LRRK2) -| bp(GO:"apoptotic process")
p(HGNC:SNCA) -| bp(GO:"apoptotic process")
p(HGNC:PRKN) -> act(a(MESH:Mitochondria))
p(HGNC:PINK1) -> act(a(MESH:Mitochondria))
p(HGNC:PARK7) -> act(a(MESH:Mitochondria))
p(HGNC:LRRK2) -> act(a(MESH:Mitochondria))
p(HGNC:SNCA) -> act(a(MESH:Mitochondria))
p(HGNC:PRKN) -| path(MESH:"Oxidative Stress")
p(HGNC:PINK1) -| path(MESH:"Oxidative Stress")
p(HGNC:PARK7) -| path(MESH:"Oxidative Stress")
p(HGNC:LRRK2) -| path(MESH:"Oxidative Stress")
p(HGNC:SNCA) -| path(MESH:"Oxidative Stress")
p(HGNC:PRKN) -> bp(GO:mitophagy)
p(HGNC:PINK1) -> bp(GO:mitophagy)
p(HGNC:PARK7) -> bp(GO:mitophagy)
p(HGNC:LRRK2) -> bp(GO:mitophagy)
p(HGNC:SNCA) -> bp(GO:mitophagy)
UNSET Cell
UNSET MeSHAnatomy

SET Evidence = " A previous study also showed that oxi-
dative stress is one of the most common causes of PD (Gaki
and Papavassiliou, 2014)."
path(MESH:"Oxidative Stress") -> path(MESH:"Parkinson Disease")

SET Evidence = "The PD-related protein named Leucine-rich repeat kinase 2
(LRRK2) was recently shown to bind to MIRO1, inducing
its degradation."
path(MESH:"Parkinson Disease") -- p(HGNC:LRRK2)
complex(p(HGNC:LRRK2),p(HGNC:RHOT1)) -> deg(p(HGNC:RHOT1))

SET Evidence = "In general, defects in the formation of autophagosomes
cause impaired mitophagy, which causes PARKIN muta-
tions that further result in neurodegenerative disorders, such
as PD (Figure 3). "
bp(GO:"autophagosome assembly") -> bp(GO:mitophagy)
bp(GO:mitophagy) -| p(HGNC:PRKN, var("?"))
p(HGNC:PRKN, var("?")) -> path(MESH:"Neurodegenerative Diseases")

SET Evidence = "In PD, the accumulation of Î±-synucelin in the SN, which
results in excessive ROS, eventually impairs the normal
mitophagic pathways to regulate the redox balance and ho-
meostasis (Gaki and Papavassiliou, 2014). "
SET MeSHDisease = "Parkinson Disease"
SET MeSHAnatomy = "Substantia Nigra"
a(HBP:"alpha-synuclein aggregates") -> a(CHEBI:"reactive oxygen species")
a(CHEBI:"reactive oxygen species") -| bp(GO:mitophagy)
UNSET MeSHAnatomy
UNSET MeSHDisease

SET Evidence = " In HD, mitochondrial ROS production and oxidation
of mitochondrial lipids play important roles in mitophagy
(Johri et al., 2013). "
SET MeSHDisease = "Huntington Disease"
SET MeSHAnatomy = "Mitochondria"
a(CHEBI:"reactive oxygen species") -- bp(GO:mitophagy)
bp(GO:"lipid oxidation") -- bp(GO:mitophagy)
UNSET MeSHAnatomy
UNSET MeSHDisease

SET Evidence = "In addition, it has been delineated that nitric oxide in-
creases mitochondrial fission in neurons, initiating neuronal
loss in a mouse model of stroke (Barsoum et al., 2006)."
SET MeSHDisease = "Stroke"
SET Species = "10090"
SET MeSHAnatomy = "Neurons"
a(CHEBI:"nitric oxide") -> bp(GO:"mitochondrial fission")
UNSET MeSHAnatomy
bp(GO:"mitochondrial fission") -| a(MESH:Neurons)
UNSET Species
UNSET MeSHDisease

SET Evidence = "Apart from these, mechanistic target of rapamycin
sequestration causes the aggregation of Huntington protein
(Htt), which results in the upregulation of autophagy or
polymorphisms in the autophagy-related gene Atg7 that fur-
ther causes HD (Barsoum et al., 2006; Jahani-Asl et al., 2007)
(Figure 3)."
a(CHEBI:sirolimus) -> a(HBP:"huntingtin aggregates")
a(HBP:"huntingtin aggregates") -> bp(GO:autophagy)
a(HBP:"huntingtin aggregates") -> p(HGNC:ATG7, var("?"))
p(HGNC:ATG7, var("?")) -> path(MESH:"Huntington Disease")

SET Evidence = "It was recently demonstrated that Htt is immense-
ly associated with mitophagy by serving as a frame for both
sequestosome 1 (SQSTM1/p62) and the autophagy-induc-
ing kinase, UNC-51-like kinase-1 (ULK1), supporting the
involvement of mutant Htt in these processes (Rui et al.,
2015)."
p(HGNC:HTT) -- bp(GO:mitophagy)

SET Evidence = " Motor neu-
ron death is caused by the dysfunction of mitochondria by
directing them toward calcium-mediated excitotoxicity, by
stimulating ROS generation and initiating the intrinsic apop-
totic pathway (Julien, 2007)."
SET MeSHDisease = "Amyotrophic Lateral Sclerosis"
SET Cell = "motor neuron"
path(HBP:"mitochondrial dysfunction") -> bp(GO:"cell death")
path(HBP:"mitochondrial dysfunction") -> bp(GO:"calcium-mediated signaling")
path(HBP:"mitochondrial dysfunction") -> a(CHEBI:"reactive oxygen species")
path(HBP:"mitochondrial dysfunction") -> path(MESH:"Apoptosis")
UNSET MeSHDisease
UNSET Cell

SET Evidence = "An increase in
the LC3II macroautophagy marker protein and a decreased
amount of phosphorylated mechanistic target of rapamy-
cin-positive motor neurons revealed impaired mitophagy
related to the loss of motor neurons in ALS (Okamoto et al.,
2010). "
SET Cell = "motor neuron"
path(MESH:"Amyotrophic Lateral Sclerosis") neg bp(GO:mitophagy)
bp(GO:mitophagy) -| bp(GO:"cell death")
UNSET Cell

SET Evidence = "Various studies have reported dysfunctional Miro in
ALS patients or animal models of the disease, including a
report of significantly lower levels of Miro1 present in spinal
cord samples of ALS patients (Zhang et al., 2015)."
act(p(HGNCGENEFAMILY:"Miro like atypical Rho GTPases")) neg path(MESH:"Amyotrophic Lateral Sclerosis")
SET MeSHAnatomy = "Spinal Cord"
path(MESH:"Amyotrophic Lateral Sclerosis") neg p(HGNC:RHOT1)
UNSET MeSHAnatomy

SET Evidence = "Mitochondrial fission and fusion hamper mitophagic
clearance, which may also be affected by mutant SOD1 (Fig-
ure 3) (Albers and Beal, 2000)."
bp(GO:"mitochondrial fission") -| bp(GO:mitophagy)
bp(GO:"mitochondrial fusion") -| bp(GO:mitophagy)
p(HGNC:SOD1, var("?")) -- bp(GO:mitophagy)

SET Evidence = "GSH levels were lower in the
motor cortex of ALS patients than those in the control vol-
unteers (Weiduschat et al., 2014), and decreased levels of
GSH result in neurological deficits and promoted the pro -
gression of mitochondrial pathology in the mutant SOD1
ALS mouse model (Vargas et al., 2011)."
SET MeSHAnatomy = "Motor Cortex"
a(PUBCHEM:124886) neg path(MESH:"Amyotrophic Lateral Sclerosis")
a(PUBCHEM:124886) -> act(a(MESH:Neurons))
SET Species = "10090"
a(PUBCHEM:124886) -| path(MESH:"Mitochondrial Diseases")
UNSET MeSHAnatomy

SET Evidence = " Mutant SOD1 has
been reported to impart Parkin-dependent degradation of
MIRO1, which may explain the mitochondrial trafficking
defect (Devine and Kittler, 2018)."
p(HGNC:SOD1, var("?")) -> act(p(HGNC:PRKN))
act(p(HGNC:PRKN)) -> deg(p(HGNC:RHOT1))
p(HGNC:SOD1, var("?")) -> deg(p(HGNC:RHOT1))
deg(p(HGNC:RHOT1)) -| bp(GO:"axonal transport of mitochondrion")

SET Evidence = "The same study also de-
scribed Miro1-knockout mice, which exhibited upper motor
neuron degeneration (Nguyen et al., 2014)."
SET Cell = "motor neuron"
p(HGNC:RHOT1) -| path(HP:Neurodegeneration)
UNSET Cell

SET Evidence = "The expression of mutant TDP-43 in a motor neuron-like
cell line induced oxidative species, mitochondrial disorder,
and the accumulation of nuclear factor protein 2 (Nrf2), a
modulator of oxidative species in a yeast model."
SET Cell = "motor neuron"
#TDP-43 is TARDBP
#Nrf2 is NFE2L2
p(HGNC:TARDBP, var("?")) -> a(CHEBI:"reactive oxygen species")
p(HGNC:TARDBP, var("?")) -> path(MESH:"Mitochondrial Diseases")
p(HGNC:NFE2L2) reg a(CHEBI:"reactive oxygen species")
p(HGNC:TARDBP, var("?")) -> p(HGNC:NFE2L2)
UNSET Cell

SET Evidence = "TDP-43-ex-
pressing cells displayed increased markers of oxidative
stress (Guareschi et al., 2012). "
p(HGNC:TARDBP) -> path(MESH:"Oxidative Stress")

SET Evidence = "Additionally, mitochondrial
disorder was noticed, together with oxidative damage, as
well as the induction of mitophagy in the mouse motor neu-
ron-like cell line (NSC34) expressing wild-type or mutant
TDP-43, representing a pathology resembling ALS."
#in TDP-43-expressing cells
p(HGNC:TARDBP) -> path(MESH:"Mitochondrial Diseases")
SET MeSHDisease = "Amyotrophic Lateral Sclerosis"
p(HGNC:TARDBP) -> bp(GO:mitophagy)
UNSET MeSHDisease

SET Evidence = " Mutant SOD1 impairs mitochondrial
retrograde axonal transport (MagranÃ© et al., 2013) along
with mitochondrial network fragmentation, indicating the
induction of mitophagy (CarrÃ¬ et al., 2017)."
p(HGNC:SOD1, var("?")) -| bp(GO:"retrograde axonal transport of mitochondrion")
p(HGNC:SOD1, var("?")) -> bp(GO:mitophagy)

SET Evidence = "Based on this review, we conclude that the loss of motor
neurons and breakdown of the redox balance cause ALS in
which ROS are an important component."
a(MESH:"Motor Neurons") -| path(MESH:"Amyotrophic Lateral Sclerosis")
bp(GO:"cell redox homeostasis") -| path(MESH:"Amyotrophic Lateral Sclerosis")
a(CHEBI:"reactive oxygen species") -- path(MESH:"Amyotrophic Lateral Sclerosis")
